CRRX logo

CareRx Corporation Stock Price

TSX:CRRX Community·CA$199.9m Market Cap
  • 3 Narratives written by author
  • 2 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

CRRX Share Price Performance

CA$3.15
0.16 (5.35%)
CA$4.50
Fair Value
CA$3.15
0.16 (5.35%)
30.0% undervalued intrinsic discount
CA$4.50
Fair Value
Price CA$3.15
AnalystLowTarget CA$4.50
AnalystConsensusTarget CA$5.14
AnalystHighTarget CA$6.05

CRRX Community Narratives

·
Fair Value CA$4.5 30.0% undervalued intrinsic discount

Canadian Healthcare Cost Cuts Will Crush Margins In Future

0users have liked this narrative
2users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$5.14 38.8% undervalued intrinsic discount

Canadian Long Term Care Expansion Will Broaden Market Reach

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
·
Fair Value CA$6.05 47.9% undervalued intrinsic discount

Aging Population And New Senior Care Beds Will Drive Powerful Long Term Tailwinds

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CA$5.14
38.8% undervalued intrinsic discount
Revenue
4.28% p.a.
Profit Margin
0.84%
Future PE
112.16x
Price in 2029
CA$6.2
CA$4.5
30.0% undervalued intrinsic discount
Revenue
3.62% p.a.
Profit Margin
1.37%
Future PE
58.96x
Price in 2029
CA$5.38
CA$6.05
47.9% undervalued intrinsic discount
Revenue
7.08% p.a.
Profit Margin
0.93%
Future PE
115.26x
Price in 2028
CA$7.31

Trending Discussion

Updated Narratives

CRRX logo

CRRX: Share Repurchases And Higher Future P/E Will Support Upside Potential

Fair Value: CA$5.14 38.8% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRRX logo

CRRX: Completed Buyback And Stable Assumptions Will Support Long Term Upside

Fair Value: CA$4.5 30.0% undervalued intrinsic discount
1 users have set this as their fair value
2 users have commented on this narrative
0 users have liked this narrative
CRRX logo

Aging Population And New Senior Care Beds Will Drive Powerful Long Term Tailwinds

Fair Value: CA$6.05 47.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with proven track record.

1 Risk
3 Rewards

CareRx Corporation Key Details

CA$374.6m

Revenue

CA$261.9m

Cost of Revenue

CA$112.7m

Gross Profit

CA$85.7m

Other Expenses

CA$27.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.43
30.09%
7.23%
36.1%
View Full Analysis

About CRRX

Founded
2001
Employees
1483
CEO
Puneet Khanna
WebsiteView website
www.carerx.ca

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

Recent CRRX News & Updates

Narrative Update Jun 01

CRRX: Share Repurchases And Higher Future P/E Will Support Upside Potential

Narrative Update on CareRx The average analyst price target for CareRx has shifted from CA$5.38 to CA$5.14. Analysts point to updated fair value estimates, a slightly higher discount rate, more cautious revenue growth assumptions, lower projected profit margins, and a higher future P/E multiple as key drivers of the change.

Recent updates

No updates